Aurobindo Pharma, Pfizer in pact

March 2009
Chemical Business;Mar2009, Vol. 23 Issue 3, p65
Trade Publication
The article announces the tie-up between Aurobindo Pharma Ltd. of Hyderabad, India and U.S.-based Pfizer Inc. for licensing and supply of medicines and sterile products from the latter. The purpose of the joint project, according to the article, is for Pfizer to exploit the sales potential of its products which suffered from loss of exclusivity (LOE) in the global market, especially in the U.S. and Europe.


Related Articles

  • Greenstone LLC.  // Chain Drug Review;9/28/2009, Vol. 31 Issue 16, p74 

    The article reports on the announcement of Pfizer Inc. on its agreement with Aurobindo Pharma Ltd. to commercialize medicines that are no longer patent-protected in the U.S. and Europe. The terms of the agreements notes Pfizer's acquisition of rights to generic solid oral dose products in the...

  • Chain Pharmacy: REPORTER'S NOTEBOOK.  // Drug Store News;5/1/2006, Vol. 28 Issue 6, p25 

    The article presents news briefs regarding suppliers of chain pharmacies in the United States. The Food and Drug Administration (FDA) has given the go signal for the first generic HIV/AIDS drug from Aurobindo Pharma. Pfizer's Lyrica is seen to become one of the successful drugs. Noven...

  • New products.  // Drug Topics;Oct2015, Vol. 159 Issue 10, p46 

    The article evaluates several new products related to pharmacy, including the Insulin degludec injection for diabetes control, from Novo Nordisk A/S, the Telmisartan tablets for the treatment of hypertension, from Aurobindo Pharma Ltd., and the Fluwar antibacterial hand sanitizer from DJO Global...

  • News bites.  // Pharmaceutical Technology Europe;Apr2009, Vol. 21 Issue 4, p8 

    The article offers world news brief related to medical topics. Genentech Inc. has been convinced by Roche to sign a merger agreement under which all the outstanding publicly held interest in Genentech Inc. for $95 per share will be acquired by Roche. Pfizer Inc. has gained the right from...

  • Aurobindo Pharma wins Australian approval for depression drug.  // PharmaWatch: CNS;Feb2010, Vol. 9 Issue 2, p12 

    The article reports that pharmaceutical firm Aurobindo Pharma Ltd. has been granted approval from the Therapeutic Goods Administration (TGA) for the registration of depression drug citalopram hydrobromide tablets in Australia.

  • Generic emtricitabine approved by FDA.  // AIDS Alert;Jul2008, Vol. 23 Issue 7, p80 

    The article reports on the tentative approval for a generic formulation of 200-milligram emtricitabine capsules granted by the U.S. Food and Drug Administration to Aurobindo Pharma Ltd. on May 9, 2008.

  • Aurobindo Pharma's US arm set to buy Natrol Inc.  // FRPT- Chemical Snapshot;11/30/2014, p5 

    The article reports that Indian firm Aurobindo Pharma Ltd. is set to buy U.S. supplements maker Natrol Inc. after its U.S. arm Aurobindo Pharma USA emerged as the highest bidder in a bankruptcy auction, and upon final approval by the U.S. Bankruptcy Court for the District of Delaware.

  • Aurobindo Q2 net up 92% at Rs 198 cr.  // Chemical Business;Nov2010, Vol. 24 Issue 11, p62 

    The article reports on a 92% increase in the consolidated net profit of Aurobindo Pharma Ltd. in the second quarter of 2010.

  • A New World perspective of globalisation.  // Marketing Week;4/27/2006, Vol. 29 Issue 17, p20 

    The article reports on the need of marketers to understand the perspective of globalization and its impact on the promotion of their brands. It has been said by predictors and sages that globalization is unavoidable and consequences happen due to its existence. Companies and industrialists must...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics